For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
CVS Health Corp (NYSE: CVS) closed the day trading at $66.73 up 1.26% from the previous closing price of $65.9. In other words, the price has increased by $1.26 from its previous closing price. On the day, 5.87 million shares were traded. CVS stock price reached its highest trading level at $67.16 during the session, while it also had its lowest trading level at $66.24.
Ratios:
For a better understanding of CVS, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 5.95 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 17.71. For the most recent quarter (mrq), Quick Ratio is recorded 0.62 and its Current Ratio is at 0.80. In the meantime, Its Debt-to-Equity ratio is 1.07 whereas as Long-Term Debt/Eq ratio is at 0.93.
On February 13, 2025, Leerink Partners Upgraded its rating to Outperform which previously was Market Perform and also upped its target price recommendation from $55 to $75.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 05 ’25 when SANSONE GUY P bought 1,570 shares for $63.70 per share. The transaction valued at 100,009 led to the insider holds 12,007 shares of the business.
ROBBINS LARRY sold 2,276,068 shares of CVS for $154,444,758 on May 02 ’25. The Director now owns 9,670,731 shares after completing the transaction at $67.86 per share. On May 05 ’25, another insider, ROBBINS LARRY, who serves as the Director of the company, sold 1,323,932 shares for $67.41 each. As a result, the insider received 89,249,945 and left with 8,346,799 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CVS now has a Market Capitalization of 84635664384 and an Enterprise Value of 153358417920. As of this moment, CVS’s Price-to-Earnings (P/E) ratio for their current fiscal year is 18.62, and their Forward P/E ratio for the next fiscal year is 9.34. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.32. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.22 while its Price-to-Book (P/B) ratio in mrq is 1.09. Its current Enterprise Value per Revenue stands at 0.399 whereas that against EBITDA is 10.975.
Stock Price History:
The Beta on a monthly basis for CVS is 0.62, which has changed by 0.14361608 over the last 52 weeks, in comparison to a change of 0.16461086 over the same period for the S&P500. Over the past 52 weeks, CVS has reached a high of $72.51, while it has fallen to a 52-week low of $43.56. The 50-Day Moving Average of the stock is 3.13%, while the 200-Day Moving Average is calculated to be 9.77%.
Shares Statistics:
Over the past 3-months, CVS traded about 7.85M shares per day on average, while over the past 10 days, CVS traded about 6655560 shares per day. A total of 1.27B shares are outstanding, with a floating share count of 1.27B. Insiders hold about 0.15% of the company’s shares, while institutions hold 87.15% stake in the company. Shares short for CVS as of 1753920000 were 15649376 with a Short Ratio of 1.99, compared to 1751241600 on 16022739. Therefore, it implies a Short% of Shares Outstanding of 15649376 and a Short% of Float of 1.25.
Dividends & Splits
CVS’s forward annual dividend rate is 2.66, up from 2.66 a year ago. Against a Trailing Annual Dividend Yield of 0.040364187The stock’s 5-year Average Dividend Yield is 3.15. The current Payout Ratio is 72.76% for CVS, which recently paid a dividend on 2025-07-22 with an ex-dividend date of 2025-07-22. Stock splits for the company last occurred on 2005-06-07 when the company split stock in a 2:1 ratio.
